Sometimes research takes scientists to unexpected places, even alpaca farms. Tobiloba Oni is one of two Valhalla Fellows at Whitehead Institute who are researching ways to harness our natural defenses to combat cancer, an ...
Jan 18, 2023
0
2
A research team at MedUni Vienna, working in cooperation with the Johns Hopkins University in Baltimore has discovered how certain dust mite allergens activate a well-known inflammatory factor—serum amyloid A protein –and ...
Jun 23, 2020
0
356
As the novel coronavirus races around the globe, mystifying patterns are emerging. The virus seems to hit some people hard—including men, people over the age of 65 and individuals with pre-existing medical conditions. For ...
Apr 27, 2020
0
4
The most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat renal cell carcinoma, a cancer with a high mortality rate that is hard to detect. Researchers from the Wellcome ...
Nov 25, 2022
0
853
Michael Green, M.D., Ph.D., noticed that when his patients had cancer that spread to the liver, they fared poorly—more so than when cancer spread to other parts of the body. Not only that, but transformative immunotherapy ...
Jan 4, 2021
0
156
A common medication used to treat reflux, heart burn and ulcers could lessen the effectiveness of lung cancer immunotherapy drugs, according to new Flinders University research.
Nov 24, 2021
0
14
A drug combination targeting multiple mutant versions of cancer's "death star" protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.
Jun 6, 2022
0
541
Chronic obstructive pulmonary disease—COPD for short—is one of the most common diseases of the lung. It affects almost 300 million people worldwide, of which about three million die every year. A collective term for chronic ...
Jan 14, 2022
0
19
Immunotherapy has revolutionized the treatment of cancer in the last decade, yet many tumors do not respond to these new therapies. A new genome-wide screen of 20,000 human genes in T cells have turned up several new candidates ...
Aug 23, 2019
0
114
Changing the microenvironment of tumors to increase the immune system's response to them has been the goal of countless research and clinical studies including the most recent use of checkpoint inhibitory antibodies. The ...
Jan 7, 2020
0
397
